Board meeting on Aug 13 to consider Q1 results and fund raise proposal

Revenue growth above 20%EBITDA margin compressionResults View source PDF Explain this filing

KRSNAA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.3%Reaction day

₹560.90

prior close

₹561.65

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.0%-0.4% vs market

Healthcare Service Provider peers, median of 26sector+0.3%-0.7% vs sector

On the reaction day the stock moved 0.4 pts less than Nifty Microcap 250 and 0.7 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

-0.2

15m

-0.5

30m

-0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.3+0.0-0.4+0.3-0.7

Next day

+0.5-0.0+0.5+0.7-0.2

+2.2-0.2+2.4+0.7+1.4

+1.8+0.2+1.6-0.0+1.8

-3.7+0.3-4.0+0.9-4.6

+2.2+0.4+1.7-1.7+3.9

-3.7+0.9-4.6-0.3-3.4

15d

+0.4+1.6-1.1+0.0+0.4

+0.7+2.0-1.3+2.9-2.2

-2.2+0.6-2.8-2.9+0.7

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Krsnaa Diagnostics has called a board meeting on Aug 13, 2026 to approve unaudited standalone and consolidated financial results for Q1 FY27, covering the quarter ended June 30, 2026. The board will also consider raising funds by issuing equity shares, fully convertible warrants, or other eligible securities to the promoter or promoter group, possibly through a preferential issue on private placement basis. The move will need shareholder, regulatory and statutory approvals. The trading window stays closed until Aug 15, 2026.

Likely market impact

Q1 results are due Aug 13. A promoter-linked fund raise may dilute non-promoter shareholders if approved.

By the numbersConsolidated · Q1 FY27 vs Q1 FY26

	Q1 FY27	Q1 FY26	Change
Revenue	₹235.5 Cr	₹193.0 Cr	+22.1%
Operating profit	₹15.19 Cr	₹23.46 Cr	−35.3%
Profit after tax	₹16.55 Cr	₹20.52 Cr	−19.3%
EBITDA margin	24.6%	26.6%	−2.0 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.